Back to RXRX
Leonteq Securities AG RXRX Position History
Recursion Pharmaceuticals, Inc.
Quarters held
11
Latest value
$134K
Q3 2026
Peak value
$510K
First seen
Q1 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2024 | $172K |
| Q2 2024 | $96K |
| Q3 2024 | $97K |
| Q4 2024 | $33K |
| Q1 2025 | $39K |
| Q2 2025 | $329K |
| Q3 2025 | $327K |
| Q4 2025 | $510K |
| Q1 2026 | $69K |
| Q2 2026 | $9K |
| Q3 2026 | $134K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $134K | 32.6K | — | — |
| Q2 2026 | $9K | 2.6K | — | — |
| Q1 2026 | $69K | 22.6K | — | — |
| Q4 2025 | $510K | 124.6K | — | — |
| Q3 2025 | $327K | 67.0K | — | — |
| Q2 2025 | $329K | 65.0K | — | — |
| Q1 2025 | $39K | 7.4K | — | — |
| Q4 2024 | $33K | 4.9K | — | — |
| Q3 2024 | $97K | 14.7K | — | — |
| Q2 2024 | $96K | 12.7K | — | — |
| Q1 2024 | $172K | 17.2K | — | — |